M
Mark S. Humayun
Researcher at University of Southern California
Publications - 653
Citations - 29453
Mark S. Humayun is an academic researcher from University of Southern California. The author has contributed to research in topics: Retina & Retinal. The author has an hindex of 84, co-authored 636 publications receiving 26997 citations. Previous affiliations of Mark S. Humayun include Lawrence Livermore National Laboratory & Duke University.
Papers
More filters
Proceedings ArticleDOI
Bioelectromagnetics for a Retinal Prosthesis to Restore Partial Vision to the Blind
TL;DR: This paper discusses modeling and computational methods to calculate the electromagnetic interaction of some of the system components with the head tissues and the safety considerations of an inductive link operating at the carrier frequency of 10 MHz and the current spread in the retina under different conditions.
Journal Article
Microelectronics Design for an Implantable High Density Retinal Prosthesis
Wentai Liu,Mohanasankar Sivaprakasam,Guoxing Wang,Mingcui Zhou,Mark S. Humayun,J. D. Weiland +5 more
Journal ArticleDOI
Focused ultrasound stimulation on meibomian glands for the treatment of evaporative dry eye.
Gengxi Lu,Sumanth Gollapudi,Runze Li,Margaret L. Pfeiffer,Preeya Mehta,Laiming Jiang,Sarah F. Hamm-Alvarez,Mark S. Humayun,Qifa Zhou,Sandy Zhang-Nunes +9 more
TL;DR: In this paper, the effectiveness of meibomian gland dysfunction treatment has been evaluated and the results showed that IBD treatment has several limitations, creating a necessity for other advanced treatment options.
Journal Article
Developing an Improved Method to Evaluate Retinitis Pigmentosa Patients for the Argus II Retinal Prosthesis System
Proceedings ArticleDOI
Biomolecular optoelectronic devices and their application to artificial sight
Elias Greenbaum,Mark S. Humayun,Tanya Kuritz,James Weifu Lee,Charlene A. Sanders,Barry D. Bruce,I. Lee +6 more
TL;DR: The goal of the project is insertion of purified Photosystem I (PSI) reaction centers or other photoactive agents into retinal cells where they will restore photoreceptor function to people who suffer from age-related macular degeneration or retinitis pigmentosa, diseases that are the leading causes of blindness world-wide.